Kissei Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Japan and operates extensively across Asia and beyond. Founded in 1946, the company has established itself as a leader in the development of innovative therapies, particularly in the fields of urology, nephrology, and diabetes management. Kissei is renowned for its unique core products, including advanced drug formulations and delivery systems that enhance patient outcomes. With a commitment to research and development, the company has achieved significant milestones, including numerous partnerships and collaborations that bolster its market position. Kissei Pharmaceutical continues to make strides in the healthcare sector, driven by its dedication to improving the quality of life for patients worldwide.
DitchCarbon Score
How does Kissei Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kissei Pharmaceutical Co., Ltd.'s score of 18 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kissei Pharmaceutical Co., Ltd.'s reported carbon emissions
In 2023, Kissei Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 88,000,000 kg CO2e, comprising 10,485,000 kg CO2e from Scope 1, 759,000 kg CO2e from Scope 2, and about 78,485,000 kg CO2e from Scope 3 emissions. This reflects a comprehensive approach to emissions reporting, including significant contributions from purchased goods and services, which accounted for approximately 67,626,000 kg CO2e. Over the years, Kissei has demonstrated a commitment to reducing its carbon footprint. In 2022, the company reported total emissions of about 14,075,000 kg CO2e, indicating a downward trend from previous years, where emissions were approximately 16,299,000 kg CO2e in 2021 and 16,297,000 kg CO2e in 2020. This consistent reduction highlights Kissei's efforts to enhance sustainability within its operations. Despite the absence of specific reduction targets or climate pledges, Kissei Pharmaceutical's emissions data illustrates a proactive stance towards climate commitments, aligning with industry standards for transparency and accountability in carbon emissions management.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | 00,000,000 |
| Scope 2 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000 |
| Scope 3 | - | - | - | - | - | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kissei Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
